Chloroquine administration in mice increases β-amyloid immunoreactivity and attenuates kainate-induced blood-brain barrier dysfunction

Neuroscience Letters

Volumn 227, Issue 3, 1997, Pages 169-172

  Mielke, John G ^a   Murphy, M Paul ^a   Maritz, Jonathan ^a   Bengualid, Karen M ^a   O Ivy, Gwen ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

amyloid; Alzheimer's disease; Astrocytes; Blood brain barrier; Chloroquine; Kainic acid

Indexed keywords

AMYLOID BETA PROTEIN; ANTIMALARIAL AGENT; CHLOROQUINE; GLIAL FIBRILLARY ACIDIC PROTEIN; KAINIC ACID;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODY SPECIFICITY; ANTIMALARIALS; ASTROCYTES; BLOOD-BRAIN BARRIER; CHLOROQUINE; EXCITATORY AMINO ACID AGONISTS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN G; KAINIC ACID; MALE; MICE; MICE, TRANSGENIC;

EID: 0030943654     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00340-6     Document Type: Article

References (21)

1. Bahr B.A., Abai B., Gall C.M., Vanderklish P.W., Hoffman K.B., Lynch G. Induction of β-amyloid-containing polypeptides in hippocampus: evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin. Exp. Neurol. 129:1994;81-94.
2. Caporaso G.L., Gandy S.E., Buxbaum J.D., Greengard P. Chloroquine inhibits intracellular degradation but not secretion of Alzheimer's β/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA. 89:1992;2252-2256.
3. Cole G.M., Huynh T.V., Saitoh T. Evidence for lysosomal processing of amyloid β-protein precursor in cultured cells. Neurochem. Res. 14:1989;933-939.
4. Esch F.S., Keim P.S., Beattie E.C., Blacher R.W., Culwell A.R., Oltersdorf T., McClure D., Ward P.J. Cleavage of amyloid β-peptide during constitutive processing of its precursor. Science. 248:1990;1122-1125.
5. Fox R.I. Mechanism of action of hydroxychloroquine as an antirheumatic drug. Semin. Arthritis Rheum. 23:(Suppl. 1):1993;82-91.
6. Golde T.E., Estus S., Younkin H.Y., Selkoe D.J., Younkin S.G. Processing of the amyloid protein precursor to potentially amyloidgenic derivatives. Science. 255:1992;728-730.
7. Goldgaber D., Lerman M.I., McBride W.O., Saffiotti U., Gajdusek D.C. Characterization and chromosomal localization of a DNA encoding brain amyloid of Alzheimer's disease. Science. 235:1987;877-880.
8. Haass C., Koo E., Mellon A., Hung A.Y., Selkoe D.J. Targeting of cell-surface β-amyloid precursor to lysosomes: alternative processing into amyloid-bearing fragments. Nature. 357:1992;500-503.
9. Kalaria R.N., Grahovac I. Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease. Brain Res. 516:1990;349-353.
10. Koh J.-Y., Yang L.L., Cotman C.W. β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533:1990;315-320.
11. Mattson M.P., Cheng B., Davis D., Bryant K., Leiberburg I., Rydel R.E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;376-389.
12. Murakami N., Ihara Y., Nonaka I. Chloroquine treated rat: a possible model for Alzheimer's disease. Muscle Nerve. 18:1995;123-125.
13. Norenberg M.D., Baker L., Norenberg L.O., Blicharska J., Bruce-Gregorios J.H., Neary J.T. Ammonia-induced astrocyte swelling in primary culture. Neurochem. Res. 16:1991;833-836.
14. Ruth R.E., Feinerman G.S. Foreign and endogenous serum protein extravasation during harmalin tremors or kainic acid seizures in the rat: a comparison. Acta Neuropathol. 76:1988;380-387.
15. Sandhu F.A., Salim M., Zain S.B. Expression of the human β-amyloid protein of Alzheimer's disease specifically in the brains of transgenic mice. J. Biol. Chem. 266:1991;21331-21334.
16. Schmidt-Kastner R., Meller D., Bellander B.-M., Strömberg I., Olson L., Ingvar M. A one-step immunohistochemical method for detection of blood-brain barrier disturbances for immunoglobins in lesioned rat brain with special reference to false-positive labelling in immunohistochemistry. J. Neurosci. Methods. 46:1993;121-132.
17. Sisodia S.S., Koo E.H., Beyreuther K., Unterbeck A., Price D.L. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science. 248:1990;492-495.
18. Stewart P.A., Hayakawa K., Akers M.-A., Vinters H.V. A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab. Invest. 67:1992;734-742.
19. Tao-Cheng J.-H., Nagy Z., Brightman M.W. Tight junctions of brain endothelium in vitro are enhanced by astroglia. J. Neurosci. 7:1987;3293-3299.
20. Thomas T., Thomas G., McLendon C., Sutton T., Mullan M. β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature. 380:1996;168-171.
21. Van Nostrand W.E., Davis-Salinas J., Saporito-Irwin S.W. Amyloid beta-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders. Ann. N. Y. Acad. Sci. 777:1996;297-302.